579 related articles for article (PubMed ID: 23731922)
1. Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina.
Hwang J; Lee HC; Kim BW; Yang MJ; Park JS; Park JH; Lee HW; Oh J; Choi JH; Cha KS; Hong TJ; Song S; Kim SP
J Cardiol; 2013 Aug; 62(2):77-81. PubMed ID: 23731922
[TBL] [Abstract][Full Text] [Related]
2. Effect of myocardial protection of intracoronary adenosine and nicorandil injection in patients undergoing non-urgent percutaneous coronary intervention: a randomized controlled trial.
Kim SJ; Kim W; Woo JS; Ha SJ; Kang WY; Hwang SH; Kang DG; Lee SU; Cho SK; Im JS; Kim W
Int J Cardiol; 2012 Jun; 158(1):88-92. PubMed ID: 21256606
[TBL] [Abstract][Full Text] [Related]
3. Effect of remote ischemia or nicorandil on myocardial injury following percutaneous coronary intervention in patients with stable coronary artery disease: A randomized controlled trial.
Miyoshi T; Ejiri K; Kohno K; Nakahama M; Doi M; Munemasa M; Murakami M; Takaishi A; Kawai Y; Sato T; Sato K; Oka T; Takahashi N; Sakuragi S; Mima A; Enko K; Hosogi S; Nanba S; Hirami R; Nakamura K; Ito H;
Int J Cardiol; 2017 Jun; 236():36-42. PubMed ID: 28214082
[TBL] [Abstract][Full Text] [Related]
4. Nicorandil prevents microvascular dysfunction resulting from PCI in patients with stable angina pectoris: a randomised study.
Hirohata A; Yamamoto K; Hirose E; Kobayashi Y; Takafuji H; Sano F; Matsumoto K; Ohara M; Yoshioka R; Takinami H; Ohe T
EuroIntervention; 2014 Jan; 9(9):1050-6. PubMed ID: 24457276
[TBL] [Abstract][Full Text] [Related]
5. Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial.
Sardella G; Lucisano L; Mancone M; Conti G; Calcagno S; Stio RE; Pennacchi M; Biondi-Zoccai G; Canali E; Fedele F
Int J Cardiol; 2013 Oct; 168(4):3715-20. PubMed ID: 23849964
[TBL] [Abstract][Full Text] [Related]
6. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous coronary intervention for poor coronary microcirculation reperfusion of patients with stable angina pectoris.
Li JS; Zhao XJ; Ma BX; Wang Z
J Biol Regul Homeost Agents; 2016; 30(3):733-741. PubMed ID: 27655490
[TBL] [Abstract][Full Text] [Related]
8. Effect of intravenous nicorandil and preexisting angina pectoris on short- and long-term outcomes in patients with a first ST-segment elevation acute myocardial infarction.
Ishii H; Ichimiya S; Kanashiro M; Amano T; Ogawa Y; Mitsuhashi H; Sakai S; Uetani T; Murakami R; Naruse K; Murohara T; Matsubara T
Am J Cardiol; 2007 May; 99(9):1203-7. PubMed ID: 17478142
[TBL] [Abstract][Full Text] [Related]
9. Intracoronary ST-segment shift soon after elective percutaneous coronary intervention accurately predicts periprocedural myocardial injury.
Balian V; Galli M; Marcassa C; Cecchin G; Child M; Barlocco F; Petrucci E; Filippini G; Michi R; Onofri M
Circulation; 2006 Oct; 114(18):1948-54. PubMed ID: 17060382
[TBL] [Abstract][Full Text] [Related]
10. Effect of estimated glomerular filtration rate on periprocedural myocardial infarction in patients undergoing elective percutaneous coronary intervention.
Vatankulu MA; Murat SN; Demircelik B; Turfan M; Sonmez O; Duran M; Bacaksiz A; Ornek E; Tasal A; Goktekin O
Ren Fail; 2013 Aug; 35(7):931-5. PubMed ID: 23803143
[TBL] [Abstract][Full Text] [Related]
11. Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.
Veselka J; Zemánek D; Hájek P; Malý M; Adlová R; Martinkovicová L; Tesar D
Am J Cardiol; 2009 Sep; 104(5):630-3. PubMed ID: 19699335
[TBL] [Abstract][Full Text] [Related]
12. Effects of liposomal prostaglandin E1 on periprocedural myocardial injury in patients with unstable angina undergoing an elective percutaneous coronary intervention.
Fan Y; Jiang Y; Fu X; Cai J; Wang Y; Li W; Gu X; Xing K; Bai S; Bi X
Coron Artery Dis; 2015 Dec; 26(8):671-7. PubMed ID: 26267747
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotective effects of intracoronary adenosine in diabetic patients undergoing elective percutaneous coronary intervention.
Shehata M
Minerva Cardioangiol; 2014 Dec; 62(6):461-71. PubMed ID: 24699551
[TBL] [Abstract][Full Text] [Related]
14. The periprocedural myocardial damage prevention during elective percutaneous coronary intervention as a result of pharmacological preconditioning with an oral form of nicorandil in patients with stable coronary artery disease. Pilot study.
Gostishchev RV; Soboleva GN; Samko AN; Rogoza AN; Minasyan AA
Ter Arkh; 2018 Sep; 90(9):53-59. PubMed ID: 30701736
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of nicorandil on myocardial injury following percutaneous coronary intervention in older patients with stable coronary artery disease: Secondary analysis of a randomized, controlled trial (RINC).
Kawakita N; Ejiri K; Miyoshi T; Kohno K; Nakahama M; Doi M; Munemasa M; Murakami M; Nakamura K; Ito H;
PLoS One; 2018; 13(4):e0194623. PubMed ID: 29659585
[TBL] [Abstract][Full Text] [Related]
16. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
[No Abstract] [Full Text] [Related]
17. Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis.
Niccoli G; Sgueglia GA; Latib A; Crea F; Colombo A;
Catheter Cardiovasc Interv; 2014 Jan; 83(1):E37-44. PubMed ID: 23813627
[TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry.
Lindsey JB; Kennedy KF; Stolker JM; Gilchrist IC; Mukherjee D; Marso SP; Pencina MJ; Kleiman NS; Cohen DJ
Circ Cardiovasc Interv; 2011 Oct; 4(5):474-80. PubMed ID: 21972402
[TBL] [Abstract][Full Text] [Related]
19. Troponin I elevation and cardiac events after percutaneous coronary intervention.
Ricciardi MJ; Davidson CJ; Gubernikoff G; Beohar N; Eckman LJ; Parker MA; Bonow RO
Am Heart J; 2003 Mar; 145(3):522-8. PubMed ID: 12660677
[TBL] [Abstract][Full Text] [Related]
20. Relationship between subclinical cardiac troponin I elevation and culprit lesion characteristics assessed by optical coherence tomography in patients undergoing elective percutaneous coronary intervention.
Lee T; Murai T; Yonetsu T; Suzuki A; Hishikari K; Kanaji Y; Matsuda J; Araki M; Niida T; Isobe M; Kakuta T
Circ Cardiovasc Interv; 2015 Apr; 8(4):. PubMed ID: 25829198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
